Blog here -
http://bit.ly/UZBKv
Monday 26 October 2009
Friday 23 October 2009
Thursday 22 October 2009
Mike Lucas on Low Dose Naltrexone
Michael Moore's colleague Mike Lucas weighs on the Low Dose Naltrexone issue -
Why won’t the drug companies shell out cash for a promising drug that requires FDA approval?
Why won’t the drug companies shell out cash for a promising drug that requires FDA approval?
Subscribe to:
Posts (Atom)